Bio-implants Market
High prevalence of disease conditions such as cardiovascular, orthopedic and spinal
disorders that are amenable to treatment via bio implants is the prime driver of the bio
implants market. For instance, cardiovascular diseases prevalence is expected to exceed
~12 million by 2020.
30% of such cardiovascular patient population are amenable to treatment via bio
implants; analogous factors exist in context of orthopedic, spinal and other disorders.
Also, development of variants of bio/raw materials that enhance biocompatibility of bio
implants (products) is expected to drive the market growth.
Advanced technologies such as 3D printing, laser and nanotechnology deployed for
manufacturing bio implants also significantly enhance biocompatibility of bio implants;
therefore, it is expected to be another key driver for the global bio implants market.
Read more at https://www.alliedmarketresearch.com/bio-implants-
market